培美曲塞|培美曲塞治疗非小细胞肺癌的最新进展( 三 )


[12]La Monica Silvia,Minari Roberta,Cretella Daniele et al. Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC.[J] .J. Exp. Clin. Cancer Res., 2019, 38: 222.
[13]Mantini Giovanna,Valentini Vincenzo,Meduri Bruno et al. Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study.[J] .Radiother Oncol, 2012, 105: 161-6.
[14]Govindan Ramaswamy,Senan Suresh,Dickgreber Nicolas et al. Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small cell lung cancer.[J] .Curr Med Res Opin, 2019, undefined: 1.

【培美曲塞|培美曲塞治疗非小细胞肺癌的最新进展】

培美曲塞|培美曲塞治疗非小细胞肺癌的最新进展